Related Experiment Video
Updated: Jan 12, 2026
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Chronic Mitral Valve Fibrosis in Rheumatic Heart Disease: From Immune Trigger to Inflammatory and Mechanical
Zhou Liu1,2, Ruifei Liu1, Jiajun Liang1,2
1Department of Cardiac Surgery Beijing Anzhen Hospital, Capital Medical University Beijing 100029 China.
Abstract:
Rheumatic heart disease is a chronic valvular disorder resulting from acute rheumatic fever, predominantly affecting the mitral valve and characterized by progressive fibrotic thickening. Although the initial insult is driven by autoimmune responses triggered by Group A Streptococcus infection, the sustained progression of valvular fibrosis involves a complex interplay of persistent immune activation, chronic inflammation, and, critically, long-term mechanical stress. Mechanical forces arising from altered hemodynamics and structural valve deformation perpetuate valvular interstitial cell activation, endothelial-to-mesenchymal transition, and extracellular matrix remodeling, thereby driving fibrosis even after acute inflammation resolves. Current therapeutic options to halt or reverse mitral valve fibrosis are limited, with surgical repair or replacement remaining the primary interventions for advanced disease. Advancing mechanistic understanding through physiologically relevant models, coupled with early diagnostic strategies and multitargeted antifibrotic approaches, holds promise for preserving valve function. Integrating molecular insights with scalable public health measures may ultimately mitigate the global burden of rheumatic heart disease and improve outcomes for affected populations.
Insights
Rheumatic heart disease causes progressive mitral valve fibrosis due to autoimmune responses and mechanical stress. New strategies targeting inflammation and fibrosis are needed to preserve valve function.
Area of Science:
- Cardiovascular Research
- Immunology
- Pathology
Background:
- Rheumatic heart disease (RHD) is a chronic valvular disorder stemming from acute rheumatic fever.
- It primarily affects the mitral valve, leading to progressive fibrotic thickening.
- The pathogenesis involves autoimmune responses to Group A Streptococcus, persistent inflammation, and mechanical stress.
Purpose of the Study:
- To explore the mechanisms driving mitral valve fibrosis in RHD.
- To identify potential therapeutic targets for halting or reversing fibrosis.
- To highlight the need for early diagnostics and scalable public health measures.
Main Methods:
- Review of existing literature on RHD pathogenesis.
- Analysis of the interplay between immune activation, inflammation, and mechanical stress.
- Discussion of current therapeutic limitations and future research directions.
Main Results:
- Valvular fibrosis in RHD is sustained by a complex interplay of factors beyond initial infection.
- Mechanical forces significantly contribute to fibrosis by activating valvular interstitial cells and promoting extracellular matrix remodeling.
- Current treatments for advanced RHD primarily involve surgical intervention.
Conclusions:
- Understanding the mechanisms of RHD fibrosis is crucial for developing new treatments.
- Physiologically relevant models, early diagnostics, and multitargeted antifibrotic therapies show promise.
- Integrating molecular insights with public health strategies can reduce the global burden of RHD.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
01:22Mitral Stenosis I: Introduction
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:27Mitral Valve Prolapse I: Introduction
01:26Mitral Stenosis III: Medical Management
01:20Mitral Regurgitation I: Introduction